Trial
NCT03559049
Rucaparib and Pembrolizumab for Maintenance Therapy in Stage IV Non-Squamous Non-Small Cell Lung Cancer
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Michigan Rogel Cancer Center
Collaborators
Merck Sharp & Dohme LLC; Clovis Oncology, Inc.
Condition
Stage IV Non-small Cell Lung Cancer
Intervention
Pembrolizumab
Why stopped
Due to financial hardships suffered by the stakeholder
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-02-12